Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Catalyst Pharmaceuticals, Inc. (CPRX) had Income from Continuous Operations of $52.70M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$152.61M |
|
$52.70M |
|
$26.07M |
|
$126.54M |
|
$90.77M |
|
$61.85M |
|
$10.05M |
|
$71.90M |
|
$71.90M |
|
$52.70M |
|
|
Income from Continuous Operations |
$52.70M |
$52.70M |
|
$52.70M |
|
$61.85M |
|
$71.38M |
|
122.29M |
|
127.26M |
|
$0.42 |
|
$0.40 |
|
| Balance Sheet Financials | |
$894.03M |
|
$1.04M |
|
$209.95M |
|
$1.10B |
|
$147.15M |
|
-- |
|
$2.56M |
|
$149.71M |
|
$954.27M |
|
$822.59M |
|
$954.27M |
|
122.51M |
|
| Cash Flow Statement Financials | |
$208.67M |
|
$-0.06M |
|
$-16.99M |
|
$517.55M |
|
$709.17M |
|
$191.62M |
|
$24.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
82.92% |
|
40.52% |
|
40.52% |
|
-- |
|
47.11% |
|
34.53% |
|
$208.61M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.70 |
|
1.21 |
|
74.59 |
|
5.52% |
|
6.41% |
|
4.77% |
|
5.52% |
|
$7.79 |
|
$1.64 |
|
$1.64 |
|